Appropriately aggregate holistic technologies via accurate expertise. Intrinsicly strategize worldwide initiatives and premium methodologies.
Divergent trajectories of antiviral memory after SARS-CoV-2 infection.
Journal article
Tomic A. et al, (2022), Nature communications, 13
Understanding the interaction between cytomegalovirus and tuberculosis in children: The way forward
Journal article
Olbrich L. et al, (2021), PLOS Pathogens, 17, e1010061 - e1010061
Efficacy of typhoid conjugate vaccine in Nepal: final results of a phase 3, randomised, controlled trial
Journal article
Shakya M. et al, (2021), The Lancet Global Health, 9, e1561 - e1568
Salmonella Typhi Vi capsule prime-boost vaccination induces convergent and functional antibody responses.
Journal article
Dahora LC. et al, (2021), Sci Immunol, 6
Vitamin D in Gambian children with discordant tuberculosis (TB) infection status despite matched TB exposure: a case control study.
Journal article
Stockdale L. et al, (2021), Eur J Pediatr
Association of Antibody-Dependent Neutrophil Phagocytosis With Distinct Antibody Glycosylation Profiles Following Typhoid Vaccination
Journal article
Johnson M. et al, (2021), Frontiers in Tropical Diseases, 2
A salmonella typhi controlled human infection study for assessing correlation between bactericidal antibodies and protection against infection induced by typhoid vaccination
Journal article
Jones E. et al, (2021), Microorganisms, 9
Author Correction: Phase 1/2 trial of SARS-CoV-2 vaccine ChAdOx1 nCoV-19 with a booster dose induces multifunctional antibody responses
Journal article
Barrett JR. et al, (2021), Nature Medicine, 27, 1113 - 1113
Author Correction: T cell and antibody responses induced by a single dose of ChAdOx1 nCoV-19 (AZD1222) vaccine in a phase 1/2 clinical trial
Journal article
Ewer KJ. et al, (2021), Nature Medicine, 27, 1116 - 1116
Single-dose administration and the influence of the timing of the booster dose on immunogenicity and efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine: a pooled analysis of four randomised trials
Journal article
Voysey M. et al, (2021), The Lancet, 397, 881 - 891
Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK
Journal article
Voysey M. et al, (2021), The Lancet, 397, 99 - 111
Performance characteristics of five immunoassays for SARS-CoV-2: a head-to-head benchmark comparison
Journal article
Ainsworth M. et al, (2020), The Lancet Infectious Diseases, 20, 1390 - 1400
Safety and immunogenicity of ChAdOx1 nCoV-19 vaccine administered in a prime-boost regimen in young and old adults (COV002): a single-blind, randomised, controlled, phase 2/3 trial
Journal article
Ramasamy MN. et al, (2020), The Lancet, 396, 1979 - 1993
Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial
Journal article
Folegatti PM. et al, (2020), The Lancet, 396, 467 - 478